Roth Capital Raises Target Price Target but Warns Q1 May Have Been a Goldilocks Quarter NTPC Q4 Profit Surges 34 YoY to Rs 10615 Crore Board Declares Rs 35 Dividend UK Exports to US Plunge 25 Following Trump Tariff Announcement BioOrbit Launches Drug Crystallization Technology on SpaceX to Space Station Targeting SelfInjected Cancer Treatments Eli Lilly Stock Ticks Up on Plans for Nearly 4 Billion in VaccineRelated Deals GlobalFoundries Targets 40 Margins on AI and Data Center Expansion KVYO Q1 2026 Earnings EPS Beat Amidst Modest Stock Decline BILI Q1 2026 Earnings EPS Surpasses Estimates by 135 Stock Gains MGY Q1 2026 Earnings Modest EPS Beat as Operational Discipline Continues SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues AEye Inc Q1 2026 Earnings WiderthanExpected Loss as Revenue Remains Absent Electrovaya ELVA Climbs 8 Support and Resistance in Focus Blaize Holdings Warrants BZAIW Surge Over 19 Key Levels in Focus Brighthouse Financial BHF Holds Steady Amid Modest Decline Key Levels in Focus C4 Therapeutics CCCC Surges 7 Biotech Momentum Test Key Resistance US Military Drill in Venezuela Raises Geopolitical Stakes Amid Political Transition OCFC Q1 2026 Earnings Earnings Per Share Surpasses Expectations Shares Edge Higher Comstock Inc LODE Surges 589 as Stock Tests Key Resistance Levels Disney DIS Edges Higher as Traders Eye Key Resistance Zone Neurogene Inc NGNE Gains Ground as Biotech Names Eye Key Levels Team Inc TISI Edges Lower Amid Consolidation Near Key Support Levels CocaCola Consolidated COKE Holds Steady Near 176 as Volume and Sector Trends Shape the Outlook Geo Group Inc GEO Declines 36 as Stock Tests Key Support Area Worthington Enterprises WOR Shows Modest Gains Testing Key Resistance Levels